United StatesRising, Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL, 473 mL (one pint), Rx only, NDC 64980-504-48, manufactured for Rising Pharma Holding and by Lyne Laboratories, is being recalled; affected lots are CR2518 (exp. 11/2027), CR2601 (exp. 12/2027), CR2602 and CR2603 (exp. 01/2028), and CR2604 and CR2605 (exp. 02/2028). The recall was issued because the medication was crystallizing and particles were floating in the bottle.
What's being recalled
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Recalling firm: Rising Pharma Holding, Inc., East Brunswick, NJ, United States.
How to identify it
Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.
The hazard
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide U.S.A.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)